Epidural Stimulation + Resistance Training for Spinal Cord Injury
(REST-SCI Trial)
Trial Summary
What is the purpose of this trial?
This trial tests a new treatment for people with severe spinal cord injuries. It combines electrical stimulation, a robotic walking suit, and muscle-strengthening exercises to help them walk and improve muscle strength. Recent advancements have combined electrical stimulation with robotic exoskeletons to facilitate movement and improve motor recovery in individuals with spinal cord injuries. The goal is to make it easier for these individuals to move and improve their overall health.
Will I have to stop taking my current medications?
The trial requires participants to stop taking anti-coagulants or anti-platelet agents, including aspirin, unless they cannot do so for medical reasons.
What data supports the effectiveness of the treatment Epidural Stimulation + Resistance Training for Spinal Cord Injury?
Research shows that epidural electrical stimulation (EES) can help improve motor function and enable voluntary control of muscle activity in people with spinal cord injuries. Additionally, combining EES with exoskeletal-assisted walking has shown potential in enhancing motor control and enabling unassisted steps in individuals with spinal cord injuries.12345
Is epidural electrical stimulation safe for humans?
How does the treatment of Epidural Stimulation + Resistance Training for Spinal Cord Injury differ from other treatments?
This treatment is unique because it combines epidural electrical stimulation (EES) with resistance training to help restore movement and standing ability in people with spinal cord injuries. EES works by stimulating the spinal cord to activate muscle movements, even in those with severe paralysis, and when combined with resistance training, it can enhance motor control and muscle strength.23456
Research Team
Ashraf S Gorgey, PhD
Principal Investigator
Virginia Commonwealth University
Eligibility Criteria
This trial is for adults aged 18-60 with traumatic motor complete spinal cord injury (SCI) at T10 level or above. They must have intact neural circuitry below the SCI as confirmed by tests, and fit specific criteria like having certain muscle responses. People with severe bone density loss, unhealed fractures, major cardiovascular issues, untreated severe spasticity or pressure sores, among other exclusions, cannot participate.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Initial Treatment
Participants undergo 6 months of exoskeletal assisted walking with epidural stimulation (EAW+ES) 3 times per week
Extended Treatment
Participants continue with 6 months of EAW+ES and add resistance training (RT) twice weekly
Follow-up
Participants are monitored for safety and effectiveness after treatment, including changes in EMG patterns, walking speed, and other health metrics
Treatment Details
Interventions
- Epidural Stimulation (Device)
- Exoskeletal assisted walking (Device)
- Resistance Training (Procedure)
Epidural Stimulation is already approved in Canada for the following indications:
- Spinal cord injury rehabilitation
- Motor function recovery
- Autonomic function recovery
Find a Clinic Near You
Who Is Running the Clinical Trial?
United States Department of Defense
Lead Sponsor
Pete Hegseth
United States Department of Defense
Chief Executive Officer
Bachelor's degree in Political Science from Princeton University, JD from Harvard Law School
Lisa Hershman
United States Department of Defense
Chief Medical Officer since 2021
MD from Uniformed Services University of the Health Sciences
Central Virginia VA Health Care System
Collaborator